Found: 6
Select item for more details and to access through your institution.
PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092181
- By:
- Publication type:
- Article
Hypertrophic osteoarthropathy from pulmonary metastatic phyllodes tumour of the breast.
- Published in:
- Medical Journal of Australia, 2004, v. 181, n. 5, p. 279, doi. 10.5694/j.1326-5377.2004.tb06272.x
- By:
- Publication type:
- Article
Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 7, p. 1302, doi. 10.3390/diagnostics11071302
- By:
- Publication type:
- Article
The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic Renal Cancer
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 1, doi. 10.1186/1471-2407-12-598
- By:
- Publication type:
- Article
The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic renal cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article